ROCHESTER — A Med City biotech firm working on gene therapies to treat dogs now — and maybe humans later — recently landed more than $330,000 in federal funding. LEAH Labs uses gene editing techniques ...
Prime Medicine, which applies a “search and replace” approach to gene editing, emerged today from stealth mode by announcing it has completed $315 million in financing. The financing consists of a ...
From left to right: Ascidian Therapeutics' Chief Financial & Business Officer Dan Rosan, Senior Vice President and Head of Research Robert Bell, and Chief Medical Officer Jay Barth. Biotechnology ...
Generative AI video editing startup OpusClip has just secured $20 million in a round led by SoftBank's Vision Fund 2. The San Francisco startup, launched in 2022, has developed a multimodal AI tool ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results